Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: Updates

Current Opinion in Oncology

Volumn 16, Issue 6, 2004, Pages 553-563

  Frankfurt, Olga ^a   Rosen, Steven T ^a,b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Apoptosis; Caspases; Glucocorticoid receptor; Glucocorticoids

Indexed keywords

CASPASE; CERAMIDE; CYTOKINE; ENDONUCLEASE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; INTERLEUKIN 6; POTASSIUM; PROTEASOME; PROTEIN BCL 2; PROTEIN KINASE C; SPHINGOMYELIN; SPHINGOSINE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CALCIUM HOMEOSTASIS; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; GENE CONTROL; GENE REPRESSION; GENETIC TRANSCRIPTION; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LEUKEMIA CELL; LYMPHOMA; LYMPHOMA CELL; MYELOMA; MYELOMA CELL; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 8344271002     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000142072.22226.09     Document Type: Review

References (140)

1. Theriault A, Boyd E, Harrap SB, et al.: Regional chromosomal assignment of the human glucocorticoid receptor gene to 5q31. Hum Genet 1989, 83:289-291.
2. Hollenberg SM, Evans RM: Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 1988, 55:899-906.
3. Greenstein S, Ghias K, Krett NL, et al.: Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 2002, 8:1681-1694.
4. Tao Y, Williams-Skipp C, Scheinman RI: Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. J Biol Chem 2001, 276:2329-2332.
5. Dahlman-Wright K, Wright A, Gustafsson JA, et al.: Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 1991, 266:3107-3112.
6. Hollenberg SM, Giguere V, Segui P, et al.: Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 1987, 49:39-46.
7. Picard D, Yamamoto KR: Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 1987, 6:3333-3340.
8. Barnes PJ: Anti-inflammatory mechanisms of glucocorticoids. Biochem Soc Trans 1995, 23:940-945.
9. Barnes PJ, Adcock I: Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993, 14:436-441.
10. Prima V, Depoix C, Masselot B, et al.: Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds. J Steroid Biochem Mol Biol 2000, 72:1-12.
11. Morishima Y, Kanelakis KC, Silverstein AM, et al.: The Hsp organizer protein hop enhances the rate of but is not essential for glucocorticoid receptor folding by the multiprotein Hsp90-based chaperone system. J Biol Chem 2000, 275:6894-6900.
12. Lamberts SW, Huizenga AT, de Lange P, et al.: Clinical aspects of glucocorlicoid sensitivity. Steroids 1996, 61:157-160.
13. Yamamoto KR, Alberts BM: Steroid receptors: elements for modulation of eukaryotic transcription. Annu Rev Biochem 1976, 45:721-746.
14. Ray A, Siegel MD, Prefontaine KE, et al.: Anti-inflammation: direct physical association and functional antagonism between transcription factor NF-KB and the glucocorticoid receptor. Chest 1995, 107(suppl 3):139S.
15. Hollenberg SM, Weinberger C, Ong ES, et al.: Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985, 318:635-641.
16. Moalli PA, Pillay S, Krett NL, et al.: Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells. Cancer Res 1993, 53:3877-3879.
17. Rivers C, Levy A, Hancock J, et al.: Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab 1999, 84:4283-4286.
18. Bamberger CM, Bamberger AM, de Castro M, et al.: Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995, 95:2435-2441.
19. Helmberg A, Auphan N, Caelles C, et al.: Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995, 14:452-460.
20. Ramdas J, Harmon JM: Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells. Endocrinology 1998, 139:3813-3821.
21. Chapman MS, Askew DJ, Kuscuoglu U, et al.: Transcriptional control of steroid-regulated apoptosis in murine thymoma cells. Mol Endocrinol 1996, 10:967-978.
22. Reichardt HM, Kaestner KH, Tuckermann J, et al.: DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998, 93:531-541.
23. Pei L: Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene. J Biol Chem 1996, 271:20879-20884.
24. Auphan N, DiDonato JA, Rosette C, et al.: Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
25. Auphan N, Didonato JA, Helmberg A, et al.: Immunoregulatory genes and immunosuppression by glucocorticoids. Arch Toxicol Suppl 1997, 19: 87-95.
26. Hartmann BL, Geley S, Loffler M, et al.: Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis. Oncogene 1999, 18:713-719.
27. Sikora E, Rossini GP, Grassilli E, et al.: Interference between DNA binding activities of AP-1 and GR transcription factors in rat thymocytes undergoing dexamethasone-induced apoptosis. Acta Biochim Pol 1996, 43:721-731.
28. Miner JN, Yamamoto KR: Regulatory crosstalk at composite response elements. Trends Biochem Sci 1991, 16:423-426.
29. Jonat C, Rahmsdorf HJ, Park KK, et al.: Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990, 62:1189-1204.
30. Rogatsky I, Zarember KA, Yamamoto KR: Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J 2001, 20:6071-6083.
31. Briehl MM, Flomerfelt FA, Wu XP, et al.: Transcriptional analyses of steroid-regulated gene networks. Mol Endocrinol 1990, 4:287-294.
32. Harrigan MT, Campbell NF, Bourgeois S: Identification of a gene induced by glucocorticoids in murine T-cells: a potential G protein-coupled receptor. Mol Endocrinol 1991, 5:1331-1338.
33. Baughman G, Harrigan MT, Campbell NF, et al.: Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol Endocrinol 1991, 5:637-644.
34. Chapman MS, Qu N, Pascoe S, et al.: Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display. Mol Cell Endocrinol 1995, 108:R1-R7.
35. Medh RD, Webb MS, Miller AL, et al.: Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics 2003, 81:543-555. The authors identified a subset of genes with an expression pattern that changed at a point immediately before apoptosis.
36. O'Connor L, Strasser A, O'Reilly LA, et al.: Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998, 17:384-395.
37. Rothermel B, Vega RB, Yang J, et al.: A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 2000, 275:8719-8725.
38. Cowell IG, Hurst HC: Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain. Nucl Acids Res 1994, 22:59-65.
39. Cowell IG, Skinner A, Hurst HC: Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol Cell Biol 1992, 12:3070-3077.
40. Woodcock EA, Wang BH, Arthur JF, et al.: Inositol polyphosphate 1-phosphatase is a novel antihypertrophic factor. J Biol Chem 2002, 277:22734-22742.
41. Haskill S, Beg AA, Tompkins SM, et al.: Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 1991, 65:1281-1289.
42. Matsuda S, Rouault J, Magaud J, et al.: In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 2001, 497:67-72.
43. Liston P, Roy N, Tamai K, et al.: Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996, 379:349-353.
44. Feder JN, Li L, Jan LY, et al.: Genomic cloning and chromosomal localization of HRY, the human homolog to the Drosophila segmentation gene, hairy. Genomics 1994, 20:56-61.
45. Tosa N, Murakami M, Jia WY, et al.: Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int Immunol 2003, 15:741-749. The authors determined that TDAG8 expression is involved in GC-mediated signals to activate caspase-9, -8, and -3.
46. Wang Z, Malone MH, Thomenius MJ, et al.: Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J Biol Chem 2003, 278:27053-27058. The authors determined that a novel gene (dig2) is induced by the GCs, and it appears to have prosurvival function.
47. Ciechanover A: The ubiquitin-proteasome proteolytic pathway. Cell 1994, 79:13-21.
48. Grimm LM, Goldberg AL, Poirier GG, et al.: Proteasomes play an essential role in thymocyte apoptosis. EMBO J 1996, 15:3835-3844.
49. Vugmeyster Y, Borodovsky A, Maurice MM, et al.: The ubiquitin-proteasome pathway in thymocyte apoptosis: caspase-dependent processing of the deubiquitinating enzyme USP7 (HAUSP). Mol Immunol 2002, 39:431-441.
50. He H, Qi XM, Grossmann J, et al.: c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis. J Biol Chem 1998, 273:25015-25019.
51. Ivanov VN, Nikolic-Zugic J: Biochemical and kinetic characterization of the glucocorticoid-induced apoptosis of immature CD4+CD8+ thymocytes. Int Immunol 1998, 10:1807-1817.
52. Gil-Gomez G, Berns A, Brady HJ: A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J 1998, 17:7209-7218.
53. Grassilli E, Benatti F, Dansi P, et al.: Inhibition of proteasome function prevents thymocyte apoptosis: involvement of ornithine decarboxylase. Biochem Biophys Res Commun 1998, 250:293-297.
54. Yang Y, Fang S, Jensen JP, et al.: Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000, 288:874-877.
55. Clark AR, Lasa M: Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol 2003, 3:404-411. In this review the authors evaluated whether the induction of proinflammatory genes and the modulation of mitogen-activated protein kinase signaling contributed to the effects of GCs.
56. Gao Y, Kinoshita Y, Hato F, et al.: Suppression of glucocorticoid-induced thymocyte apoptosis by co-culture with thymic epithelial cells. Cell Mol Biol 1996, 42:227-234.
57. Ferlin-Bezombes M, Jourdan M, Liautard J, et al.: IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis. J Immunol 1998, 161:2692-2699.
58. Chauhan D, Pandey P, Ogata A, et al.: Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism. Oncogene 1997, 15:837-843.
59. Xu FH, Sharma S, Gardner A, et al.: Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 1998, 92:241-251.
60. Van Snick J, Houssiau F, Proost P, et al.: I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J Immunol 1996, 157:2570-2576.
61. Bauer JH, Liu KD, You Y, et al.: Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem 1998, 273:9255-9260.
62. Bulfone-Paus S, Ungureanu D, Pohl T, et al.: Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997, 3:1124-1128.
63. Ogawa M, Nishiura T, Oritani K, et al.: Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line. Cancer Res 2000, 60:4262-4269.
64. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
65. Li Q, Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
66. Rayet B, Gelinas C: Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999, 18:6938-6947.
67. Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 2002, 3:221-227.
68. Ben-Neriah Y: Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002, 3:20-26.
69. Ghosh S, Karin M: Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(suppl):S81-S96.
70. Xie H, Seward RJ, Huber BT: Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IkappaBalpha. Mol Immunol 1997, 34:987-994.
71. Adcock IM, Nasuhara Y, Stevens DA, et al.: Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targeting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol 1999, 127:1003-1011.
72. Asada A, Zhao Y, Kondo S, et al.: Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J Biol Chem 1998, 273:28392-28398.
73. Hideshima T, Nakamura N, Chauhan D, et al.: Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 2001, 20:5991-6000.
74. Chauhan D, Pandey P, Hideshima T, et al.: SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells. J Biol Chem 2000, 275:27845-27850.
75. Jamieson CA, Yamamoto KR: Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. Proc Natl Acad Sci USA 2000, 97:7319-7324.
76. Refojo D, Liberman AC, Giacomini D, et al.: Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells. Ann N Y Acad Sci 2003, 992:196-204.
77. Thompson EB: The many roles of c-Myc in apoptosis. Annu Rev Physiol 1998, 60:575-600.
78. Ausserlechner MJ, Obexer P, Bock G, et al.: Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells. Cell Death Differ 2004, 11:165-174. The authors investigated how GCs interfere with cell cycle progression and how this relates to apoptosis induction in human CCRF-CEM cells. They analyzed the functional significance of cyclin D3 and c-myc repression for GC-induced cell cycle arrest and whether this was a prerequisite for GC-induced apoptosis.
79. Burger R, Bakker F, Guenther A, et al.: Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival. Br J Haematol 2003, 123:869-878. The authors established that a novel cytokine, B-cell stimulating factor-3/cardiotrophin-like cytokine, provides growth and survival signals for human myeloma cells via an IL-6-independent mechanism.
80. Marsden VS, Strasser A: Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 2003, 21:71-105. This is an excellent review of the role of the Bcl-2 protein family in cell survival and apoptosis.
81. Gross A: BCL-2 proteins: regulators of the mitochondrial apoptotic program. IUBMB Life 2001, 52:231-236.
82. Gross A, McDonnell JM, Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999, 13:1899-1911.
83. Alnemri ES, Fernandes TF, Haldar S, et al.: Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 1992, 52:491-495.
84. Moreaux J, Legouffe E, Jourdan E, et al.: BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004, 103:3148-3157. The authors evaluated the pattern of gene expression and mechanism of action of BAFF and APRIL receptors in myeloma cell lines. They determined that BAFF and APRIL are potent growth factors, able to rescue myeloma cells from GC-induced apoptosis.
85. Veis DJ, Sorenson CM, Shutter JR, et al.: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993, 75:229-240.
86. Memon SA, Moreno MB, Petrak D, et al.: Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J Immunol 1995, 155:4644-4652.
87. Caron-Leslie LA, Evans RB, Cidlowski JA: Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J 1994, 8:639-645.
88. Mok CL, Gil-Gomez G, Williams O, et al.: Bad can act as a key regulator of T cell apoptosis and T cell development. J Exp Med 1999, 189:575-586.
89. Broome HE, Yu AL, Diccianni M, et al.: Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. Leuk Res 2002, 26:311-316.
90. Rogatsky I, Hittelman AB, Pearce D, et al.: Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids. Mol Cell Biol 1999, 19:5036-5049.
91. 2 production during GC-induced apoptosis.
92. Smets LA, van den Berg JD: Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cells. Leuk Lymphoma 1996, 20:199-205.
93. Smets LA, Van den Berg J, Acton D, et al.: BCL-2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis. Blood 1994, 84:1613-1619.
94. Wang Z, Malone MH, He H, et al.: Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 2003, 278:23861-23867. The authors used oligonucleotide microarrays to identify sets of GC-regulated genes in T-cell lymphoma cell lines. They were the first group to determine that the proapoptotic protein Bim, capable of directly initiating the apoptotic cascade, is induced after GC treatment.
95. Wang HG, Pathan N, Ethell IM, et al.: Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999, 284:339-343.
96. Kino T, Souvatzoglou E, De Martino MU, et al.: Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J Biol Chem 2003, 278:25651-25656. The authors examined the physiologic role of 14-3-3 protein on the GC signaling pathway.
97. Zha J, Harada H, Yang E, et al.: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87:619-628.
98. Brunet CL, Gunby RH, Benson RS, et al.: Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ 1998, 5:107-115.
99. Feinman R, Koury J, Thames M, et al.: Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 1999, 93:3044-3052.
100. Gardner JP, Zhang L: Glucocorticoid modulation of Ca2+ homeostasis in human B lymphoblasts. J Physiol 1999, 514:385-396.
101. Distelhorst CW, Dubyak G: Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: resurrection of old theories by new findings. Blood 1998, 91:731-734.
102. Bian X, Hughes FM Jr, Huang Y, et al.: Roles of cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of apoptosis in S49 cells. Am J Physiol 1997, 272:C1241-C1249.
103. Squier MK, Cohen JJ: Calpain, an upstream regulator of thymocyte apoptosis. J Immunol 1997, 158:3690-3697.
104. Khan AA, Soloski MJ, Sharp AH, et al.: Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-triphosphate receptor. Science 1996, 273:503-507.
105. Jayaraman T, Marks AR: T cells deficient in inositol 1,4,5-triphosphate receptor are resistant to apoptosis. Mol Cell Biol 1997, 17:3005-3012.
106. Chvatchko Y, Valera S, Aubry JP, et al.: The involvement of an ATP-gated ion channel, P(2X1), in thymocyte apoptosis. Immunity 1996, 5:275-283.
107. Jiang S, Kull B, Fredhoim BB, et al.: P2x purinoceptor is not important in thymocyte apoptosis. Immunol Lett 1996, 49:197-201.
108. Le Stunff H, Auger R, Kanellopoulos J, et al.: The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J Biol Chem 2004, 279:16918-16926.
109. Peters SM, Tijsen MJ, Bindels RJ, et al.: Rise in cytosolic Ca2+ and collapse of mitochondrial potential in anoxic, but not hypoxic, rat proximal tubules. J Am Soc Nephrol 1996, 7:2348-2356.
110. Wood DE, Newcomb EW: Cleavage of Bax enhances its cell death function. Exp Cell Res 2000, 256:375-382.
111. Wood DE, Thomas A, Devi LA, et al.: Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 1998, 17:1069-1078.
112. Shimizu S, Konishi A, Kodama T, et al.: BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci U S A 2000, 97:3100-3105.
113. Bortner CD, Cidlowski JA: Volume regulation and ion transport during apoptosis. Methods Enzymol 2000, 322:421-433.
114. + ions concentration, volume loss, and apoptosis.
115. Benson RS, Heer S, Dive C, et al.: Characterization of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am J Physiol 1996, 270:C1190-C1203.
116. Hughes FM Jr, Bortner CD, Purdy GD, et al.: Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem 1997, 272:30567.
117. Dallaporta B, Marchetti P, de Pablo MA, et al.: Plasma membrane potential in thymocyte apoptosis. J Immunol 1999, 162:6534-6542.
118. Bortner CD, Hughes FM Jr, Cidlowski JA: A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 1997, 272:32436-32442.
119. Kolesnick R, Fuks Z: Radiation and ceramide-induced apoptosis. Oncogene 2003, 22:5897-5906. The authors evaluated the role of ceramide in apoptosis.
120. Kolesnick RN, Kranke M: Regulation of ceramide production and apoptosis. Annu Rev Physiol 1998, 60:643-665.
121. Cifone MG, Migliorati G, Parroni R, et al.: Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 1999, 93:2282-2296.
122. Marchetti MC, Di Marco B, Cifone G, et al.: Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 2003, 101:585-593. The authors analyzed the molecular mechanisms of GC-induced apoptosis. In particular, they attempted to define the role of GR-associated Src kinase; the role of activation of caspase-8, -9, and -3; as well as a role of cytochrome c release.
123. Sweeney EA, Sakakura C, Shirahama T, et al.: Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int J Cancer 1996, 66:358-366.
124. Cuvillier O, Edsall L, Spiegel S: Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem 2000, 275:15691-15700.
125. Lepine S, Lakatos B, Maziere P, et al.: Involvement of sphingosine in dexamethasone-induced thymocyte apoptosis. Ann N Y Acad Sci 2002, 973:190-193.
126. Newmeyer DD, Farschon DM, Reed JC: Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 1994, 79:353-364.
127. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998, 281: 1309-1312.
128. Castedo M, Hirsch T, Susin SA, et al.: Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996, 157:512-521.
129. Chauhan D, Pandey P, Ogata A, et al.: Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells. J Biol Chem 1997, 272:29995-29997.
130. Hakem R, Hakem A, Duncan GS, et al.: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998, 94:339-352.
131. Miyashita T, Nagao K, Krajewski S, et al.: Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3. Cell Death Differ 1998, 5:107-115.
132. Benson RS, Dive C, Watson AJ: Comparative effects of Bcl-2 overexpression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cells. Cell Death Differ 1998, 5:432-439.
133. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998, 281:1312-1316.
134. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
135. Saleh A, Srinivasula SM, Acharya S, et al.: Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 1999, 274:17941-17945.
136. Li H, Zhu H, Xu CJ, et al.: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501.
137. Yoshida H, Kong YY, Yoshida R, et al.: Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998, 94:739-750.
138. Kuida K, Haydar TF, Kuan CY, et al.: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998, 94:325-337.
139. Kuida K, Zheng TS, Na S, et al.: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996, 384:368-372.
140. Planey SL, Abrams MT, Robertson NM, et al.: Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res 2003, 63:172-178. The authors attempted to clarify the pattern of caspases activation in GC-mediated apoptosis in pre-B leukemic cell lines. In addition, they identified 113 GR-regulated genes upstream of caspase activation.